1. A therapeutic or prophylactic agent for biliary tract disease (s), said agent containing as an effective component the compound represented by the general formula (I) below: wherein the double line, consisting of a dashed line and a solid line, is a double bond or a single bond, R is CC-cycloalkylalkyl, R is linear or branched CC-alkyl, and B is —CH═CH — or a pharmaceutically acceptable acid addition salt thereof. 2. The therapeutic or prophylactic agent for biliary tract disease (s) according to claim 1, wherein in the general formula (I), R is cyclopropylmethyl, cyclobutylmethyl, cyclopentylmethyl or cyclohexylmethyl, and R is methyl, ethyl or propyl. 3. The therapeutic or prophylactic agent for biliary tract disease (s) according to claim 1, wherein said compound represented by General Formula (I) is (-) - 17- (cyclopropylmethyl) -3,14β-dihydroxy-4,5α-epoxy-6β - [N-methyl-trans-3- (3-furyl) acrylamido] morphinan. 4. A therapeutic or prophylactic agent for biliary tract disease (s) according to any one of claims 1 to 3, wherein said (one or more) biliary tract disease is a blockage of the biliary tract, gallbladder disorder, gallstone disease, pancreatitis, biliary dyskinesia, cholangitis, cholecystitis and / or primary biliary cirrhosis. 5. A therapeutic or prophylactic agent for biliary tract disease (s) according to any one of claims 1 to 3, wherein said agent has a therapeutic or prophylactic effect for biliary tract disease (s) by inhibiting contractile1. Терапевтическое или профилактическое средство при заболевании(ях) желчных путей, причем указанное средство содержит в качестве эффективного компонента соединение, представленное ниже общей формулой (I):где двойная линия, состоящая из пунктирной линии и сплошной линии, представляет собой двойную связь или одинарную связь, Rпредставляет собой C-C-циклоалкилалкил, Rпредставляет собой линейный или разветвленный C-C-алкил, а B представляет собой -CH=CH-или его фармацевтически приемлемую кислотно-аддитивную сол
